Table 1.
Differentially expressed proteins in malignant glioma (in alphabetical order)
| Protein | NCBI Gene Number | Description |
|---|---|---|
| C17orf66 | 256957 | chromosome 17 open reading frame 66 |
| FBXO18 | 84893 | F-box protein, helicase, 18 |
| JAM3 | 83700 | junctional adhesion molecule 3 |
| OCRL | 4952 | oculocerebrorenal syndrome of Lowe |
| OLIG2 | 10215 | oligodendrocyte lineage transcription factor 2 |
| PBXIP1 | 57326 | pre-B-cell leukemia homeobox interacting protein 1 |
| SQSTM1 | 8878 | sequestosome 1 |
| SYF2 | 25949 | SYF2 homolog, RNA splicing factor (S. cerevisiae) |
| SYT5 | 6861 | synaptotagmin V |
| ZCCHC16 | 340595 | zinc finger, CCHC domain containing 16 |
| ZFPM2 | 23414 | zinc finger protein, multitype 2 |
In silico proteomic analysis using The Human Protein Atlas reveals proteins differentially overexpressed (strong staining) in > 80% of malignant glioma cases compared with weak – negative staining in glial and neuronal cells in nonmalignant cerebral cortex.